Pediatric Dose-Reduction Protocols for Head CT: Do Hospitals Use Them?
Use of pediatric dose-reduction protocols and shielding for CTs vary among hospitals.
Over 90 percent of surveyed community hospitals in the U.S. used pediatric protocols for head CTs but not as many use shielding, according to an article published in the Journal of the American College of Radiology.
Researchers from Washington State University in Spokane examined hospital-level factors associated with the use of dedicated pediatric dose-reduction protocols by sending out surveys (online and paper) to a stratified random sample of community hospitals. The survey focused on CT scans for head trauma among children.
A total of 751 hospitals were approached and 253 responded for a response rate of 35.5 percent. Of the respondents, 92.6 percent reported that they used a pediatric dose-reduction protocol. Of 251 that used external shielding, 176 (70.1 percent) used the shielding for CT head and neck imaging.
Free–response indication of organs shielded:
“Small hospitals (0 to 50 beds) were 20 percent less likely to report using a protocol than large hospitals (more than 150 beds). Teaching hospitals were more likely to report using a protocol,” the authors wrote. “After adjusting for covariates, children's hospitals were significantly less likely to report using protective shielding than nonchildren's hospitals, though this may be due to more advanced scanner type.”
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
